JP2023504282A5 - - Google Patents

Info

Publication number
JP2023504282A5
JP2023504282A5 JP2022534255A JP2022534255A JP2023504282A5 JP 2023504282 A5 JP2023504282 A5 JP 2023504282A5 JP 2022534255 A JP2022534255 A JP 2022534255A JP 2022534255 A JP2022534255 A JP 2022534255A JP 2023504282 A5 JP2023504282 A5 JP 2023504282A5
Authority
JP
Japan
Prior art keywords
emulsion
therapeutic protein
nanospheres
cytokine
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022534255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504282A (ja
JP7818514B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063314 external-priority patent/WO2021113638A1/en
Publication of JP2023504282A publication Critical patent/JP2023504282A/ja
Publication of JP2023504282A5 publication Critical patent/JP2023504282A5/ja
Application granted granted Critical
Publication of JP7818514B2 publication Critical patent/JP7818514B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022534255A 2019-12-05 2020-12-04 タンパク質を搭載したｐｌｇａナノスフィア Active JP7818514B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962944191P 2019-12-05 2019-12-05
US62/944,191 2019-12-05
PCT/US2020/063314 WO2021113638A1 (en) 2019-12-05 2020-12-04 Protein-loaded plga nanospheres

Publications (3)

Publication Number Publication Date
JP2023504282A JP2023504282A (ja) 2023-02-02
JP2023504282A5 true JP2023504282A5 (https=) 2023-12-12
JP7818514B2 JP7818514B2 (ja) 2026-02-20

Family

ID=76221229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022534255A Active JP7818514B2 (ja) 2019-12-05 2020-12-04 タンパク質を搭載したｐｌｇａナノスフィア

Country Status (11)

Country Link
US (3) US12214046B2 (https=)
EP (1) EP4072536A4 (https=)
JP (1) JP7818514B2 (https=)
KR (1) KR20220143811A (https=)
CN (1) CN115335041A (https=)
AU (1) AU2020396557A1 (https=)
BR (1) BR112022010952A2 (https=)
CA (1) CA3160922A1 (https=)
IL (1) IL293607A (https=)
MX (1) MX2022006824A (https=)
WO (1) WO2021113638A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021113638A1 (en) 2019-12-05 2021-06-10 West Virginia University Protein-loaded plga nanospheres
CN116855571B (zh) * 2023-06-26 2025-03-21 中国农业大学 Plga纳米球病毒示踪剂及其制备方法与应用
KR20250069077A (ko) * 2023-11-10 2025-05-19 아주대학교산학협력단 패티케이션 기술을 적용한 쿠에티아핀-지방산 접합체 나노입자 및 이의 장기 지속형 주사제 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
FR2793684B1 (fr) 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US20040003402A1 (en) 2002-06-27 2004-01-01 Digeo, Inc. Method and apparatus for automatic ticker generation based on implicit or explicit profiling
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
US20070026005A1 (en) * 2003-09-09 2007-02-01 Sung Young C Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
KR100622996B1 (ko) * 2005-03-03 2006-09-14 한국과학기술원 약물이 봉입된 비다공성 고분자 미립 담체 및 이의 제조방법
WO2007074604A1 (ja) 2005-12-26 2007-07-05 Ltt Bio-Pharma Co., Ltd. 水溶性非ペプチド性低分子薬物含有ナノ粒子
US10265407B2 (en) 2007-02-15 2019-04-23 Yale University Modular nanodevices for smart adaptable vaccines
EP2251006B1 (en) 2008-02-22 2017-07-19 Toray Industries, Inc. Microparticles and pharmaceutical compositions thereof
US9972047B1 (en) 2008-04-18 2018-05-15 Capital One Services, Llc Systems and methods for performing a purchase transaction using rewards points
US20090281888A1 (en) 2008-05-09 2009-11-12 Li-Cheng Richard Zai Method And Apparatus For Establishing Time-Based Loyalty Relationship
EA020954B1 (ru) 2008-06-16 2015-03-31 Бинд Терапьютикс, Инк. Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
RU2011126338A (ru) * 2008-11-28 2013-01-10 Эбботт Лэборетриз Стабильные композиции антител и способы их стабилизации
WO2011063177A1 (en) 2009-11-20 2011-05-26 Mobisave Corporation System and method of electronically verifying required proof-of-performance to secure promotional rewards
WO2011119262A1 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc. Methods and systems for generating nanoparticles
US9782342B2 (en) * 2010-10-11 2017-10-10 Wichita State University Composite magnetic nanoparticle drug delivery system
BR112014006596A2 (pt) * 2011-09-21 2017-03-28 Yissum Res Dev Co nanopartícula que encapsula uma pluralidade de nanocarreadores, composição, uso de uma nanopartícula, kit, sistema de entrega, processo para obter uma nanopartícula, e, processo de nanoaspersão para obter as nanopartículas
US9562015B2 (en) * 2011-11-17 2017-02-07 The Regents Of The University Of Colorado, A Body Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
CA2869748C (en) * 2012-04-12 2017-10-24 Yale University Vehicles for controlled delivery of different pharmaceutical agents
WO2013166487A1 (en) 2012-05-04 2013-11-07 Yale University Highly penetrative nanocarriers for treatment of cns disease
US9724304B2 (en) 2012-06-14 2017-08-08 Temple University—Of the Commonwealth System of Higher Education Nanospheres for therapeutic agent delivery
US9308172B2 (en) 2012-10-26 2016-04-12 Board Of Trustees Of Michigan State University Device and method for encapsulation of hydrophilic materials
CA2929277C (en) * 2013-11-01 2018-01-16 Yale University Delivery vehicles comprising il-2 and losartan
WO2016061201A1 (en) * 2014-10-14 2016-04-21 The Brigham And Women's Hospital, Inc. Nanoparticles and methods of use
CN104622795B (zh) * 2015-01-28 2017-12-08 杭州市萧山区中医院 一种多细胞因子序贯缓释微球‑水凝胶复合系统及其制备方法
CN108064176A (zh) 2015-04-22 2018-05-22 库瑞瓦格股份公司 用于治疗肿瘤疾病的含有rna的组合物
US20170056327A1 (en) * 2015-08-25 2017-03-02 The Methodist Hospital Micro/nano composite drug delivery formulations and uses thereof
WO2019162951A1 (en) * 2018-02-26 2019-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Drug delivery systems
EP3987054A4 (en) 2019-06-18 2023-06-14 Biomeme Incorporated SAMPLE ANALYSIS SYSTEMS
WO2021113638A1 (en) 2019-12-05 2021-06-10 West Virginia University Protein-loaded plga nanospheres

Similar Documents

Publication Publication Date Title
JP2023504282A5 (https=)
CN1132625C (zh) 包胶在透明质酸微粒中的缓释药物组合物
US20250064949A1 (en) Protein-loaded plga nanospheres
JP2002534459A (ja) タンパク質薬物または抗原を含む、親油性微細粒子およびそれを含む剤形
CN1549728A (zh) 在可生物降解的微球体中含有抗原、基因载体和佐剂的免疫组合物
EP1638534B1 (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
JP2012524793A (ja) 免疫調節性生体分子を組み合わせて送達するためのヒドロゲル
JP2009149526A (ja) サイトカイン−ナノゲル複合体を含む皮下注射又は筋肉内注射徐放製剤
JP2023548560A5 (https=)
Karem et al. Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains
CN1343125A (zh) 癌症治疗中的免疫刺激剂细菌膜组分
JP2641755B2 (ja) コントロールリリース製剤
JPH03502574A (ja) メチルセルロース製薬学的組成物
JP3492671B2 (ja) 免疫アジュバント
JP2004508290A (ja) 免疫調節における粒状ベクターの使用
CN1692943A (zh) CpG DNA分子抗感染免疫制剂的制备和应用
JP2001010961A (ja) 腫瘍ワクチン
HK40083735A (en) Protein-loaded plga nanospheres
CN116115565B (zh) 一种plga纳米乳及其制备和在副结核疫苗中的应用
EP2925297B1 (en) Composition comprising cytokine macro-aggregates
CN116712565A (zh) 一种口服胃癌疫苗
CN119818662A (zh) 一种丝胶磷酸钙纳米肿瘤疫苗的制备方法及其应用
CN1720922A (zh) CpG寡聚核苷酸抗感染DNA制剂的制备及应用技术
CN114681607A (zh) 一种流感疫苗经鼻递送系统
HK1089954B (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix